| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8784915 | Advances in Radiation Oncology | 2017 | 23 Pages |
Abstract
These results complement the limited existing body of literature by demonstrating that SBRT provides good control of treated adrenal gland metastasis; however, high-grade late toxicities may occur. More stringent dose constraint limits may prevent associated serious adverse events.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Kristin MD, PhD, Nathan BS, Muhammed MD, Taher Abu MBBS, Gerald H. MD, Jun MD, PhD, Ryan T. PhD, Sudershan K. MD, PhD, Mark C. MD, John M. MD, Bryan G. MD, PhD,